Trials / Recruiting
RecruitingNCT07275970
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Suzanne "Sue" Sisley MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psychedelic | Organic Whole Psilocybin-Containing Mushrooms |
Timeline
- Start date
- 2026-02-09
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-12-10
- Last updated
- 2026-03-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07275970. Inclusion in this directory is not an endorsement.